CASP, the protein structure prediction contest that launched DeepMind’s AlphaFold to international fame and a Nobel Prize, ...

In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...

Google’s GNoME AI might be the most important scientific discovery tool since AlphaFold. By identifying novel, stable ...

Demis Hassabis, the cofounder and CEO of DeepMind, is one of three researchers to be awarded the Nobel Prize in chemistry.

A three-decade-old competition that has spawned three Nobel laureates is becoming victim to the chaos at the National Institutes of Health.

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

The Rise of AlphaFold as a Standard Laboratory Tool And Applications in Drug Discovery Serendipitously, on the 20th of September, 2023, I was having coffee with Dr. Michael Levitt. In 2013 ...

DeepMind’s AlphaFold program has been upgraded since last year’s CASP competition and is now 16 times faster. “We can fold an average protein in a matter of minutes, ...

AlphaFold 3 represents a significant milestone in AI-powered molecular discovery, but it is just the beginning. As researchers continue to push the boundaries of what’s possible with these ...

AlphaFold’s strategy is similar to most entries in CASP this year, in that it relies on deep learning. Remember: amino acid sequences, the building blocks of proteins, contain data about a protein’s ...

The AlphaFold data will be no exception; once the above link is live, anyone can use it to download information on the human protein of their choice. Or, as mentioned above, ...

Researchers used AlphaFold and homology modeling to identify potent TAAR1 agonists, showing AlphaFold's superior performance in drug discovery for neuropsychiatric conditions.